These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 24689236)
21. Double Sonogashira reactions on dihalogenated aminopyridines for the assembly of an array of 7-azaindoles bearing triazole and quinoxaline substituents at C-5: Inhibitory bioactivity against Giardia duodenalis trophozoites. Leboho TC; Giri S; Popova I; Cock I; Michael JP; de Koning CB Bioorg Med Chem; 2015 Aug; 23(15):4943-4951. PubMed ID: 26043947 [TBL] [Abstract][Full Text] [Related]
22. Synthesis of isoquinolinone-based tetracycles as poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors. Rhee HK; Lim SY; Jung MJ; Kwon Y; Kim MH; Choo HY Bioorg Med Chem; 2009 Nov; 17(21):7537-41. PubMed ID: 19800803 [TBL] [Abstract][Full Text] [Related]
23. N-substituted azaindoles as potent inhibitors of Cdc7 kinase. Bryan MC; Falsey JR; Frohn M; Reichelt A; Yao G; Bartberger MD; Bailis JM; Zalameda L; Miguel TS; Doherty EM; Allen JG Bioorg Med Chem Lett; 2013 Apr; 23(7):2056-60. PubMed ID: 23481650 [TBL] [Abstract][Full Text] [Related]
24. 7-Azaindole-1-carboxamides as a new class of PARP-1 inhibitors. Cincinelli R; Musso L; Merlini L; Giannini G; Vesci L; Milazzo FM; Carenini N; Perego P; Penco S; Artali R; Zunino F; Pisano C; Dallavalle S Bioorg Med Chem; 2014 Feb; 22(3):1089-103. PubMed ID: 24398383 [TBL] [Abstract][Full Text] [Related]
25. Facile one-pot synthesis, antiproliferative evaluation and structure-activity relationships of 3-amino-1H-indoles and 3-amino-1H-7-azaindoles. Diao PC; Hu MJ; Yang HK; You WW; Zhao PL Bioorg Chem; 2019 Jul; 88():102914. PubMed ID: 30991193 [TBL] [Abstract][Full Text] [Related]
27. Synthesis of 4- and 6-azaindoles via the Fischer reaction. Jeanty M; Blu J; Suzenet F; Guillaumet G Org Lett; 2009 Nov; 11(22):5142-5. PubMed ID: 19839585 [TBL] [Abstract][Full Text] [Related]
28. 7-Azaindole derivatives as potential partial nicotinic agonists. Stoit AR; den Hartog AP; Mons H; van Schaik S; Barkhuijsen N; Stroomer C; Coolen HK; Reinders JH; Adolfs TJ; van der Neut M; Keizer H; Kruse CG Bioorg Med Chem Lett; 2008 Jan; 18(1):188-93. PubMed ID: 18006307 [TBL] [Abstract][Full Text] [Related]
29. 1,2-Disubstituted indole, azaindole and benzimidazole derivatives possessing amine moiety: a novel series of thrombin inhibitors. Takeuchi K; Bastian JA; Gifford-Moore DS; Harper RW; Miller SC; Mullaney JT; Sall DJ; Smith GF; Zhang M; Fisher MJ Bioorg Med Chem Lett; 2000 Oct; 10(20):2347-51. PubMed ID: 11055353 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of substituted 2-phenyl-2H-indazole-7-carboxamides as potent poly(ADP-ribose) polymerase (PARP) inhibitors. Scarpelli R; Boueres JK; Cerretani M; Ferrigno F; Ontoria JM; Rowley M; Schultz-Fademrecht C; Toniatti C; Jones P Bioorg Med Chem Lett; 2010 Jan; 20(2):488-92. PubMed ID: 20007017 [TBL] [Abstract][Full Text] [Related]
31. Organometallic methods for the synthesis and functionalization of azaindoles. Song JJ; Reeves JT; Gallou F; Tan Z; Yee NK; Senanayake CH Chem Soc Rev; 2007 Jul; 36(7):1120-32. PubMed ID: 17576479 [TBL] [Abstract][Full Text] [Related]
32. Effect of simulated microgravity conditions on poly(ADP-ribose) polymerase activity in primary cultures of adult rat hepatocytes. Cesarone CF; Pippia P; Demori I; Scarabelli L; Fugassa E J Gravit Physiol; 2001 Jul; 8(1):P127-8. PubMed ID: 12650200 [TBL] [Abstract][Full Text] [Related]
33. Bivalent Smac mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents. Peng Y; Sun H; Lu J; Liu L; Cai Q; Shen R; Yang CY; Yi H; Wang S J Med Chem; 2012 Jan; 55(1):106-14. PubMed ID: 22148838 [TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and antiproliferative activity of a novel class of indole-2-carboxylate derivatives. Ji XY; Xue ST; Zhan YC; Shen JJ; Wu LT; Jin J; Wang Z; Li ZR Eur J Med Chem; 2014 Aug; 83():409-18. PubMed ID: 24996136 [TBL] [Abstract][Full Text] [Related]
35. Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology. Ratnam K; Low JA Clin Cancer Res; 2007 Mar; 13(5):1383-8. PubMed ID: 17332279 [TBL] [Abstract][Full Text] [Related]
36. The importance of indole and azaindole scaffold in the development of antitumor agents. Han Y; Dong W; Guo Q; Li X; Huang L Eur J Med Chem; 2020 Oct; 203():112506. PubMed ID: 32688198 [TBL] [Abstract][Full Text] [Related]
37. Identification of potent nontoxic poly(ADP-Ribose) polymerase-1 inhibitors: chemopotentiation and pharmacological studies. Calabrese CR; Batey MA; Thomas HD; Durkacz BW; Wang LZ; Kyle S; Skalitzky D; Li J; Zhang C; Boritzki T; Maegley K; Calvert AH; Hostomsky Z; Newell DR; Curtin NJ Clin Cancer Res; 2003 Jul; 9(7):2711-8. PubMed ID: 12855651 [TBL] [Abstract][Full Text] [Related]
38. Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy. Heitz F; Harter P; Ewald-Riegler N; Papsdorf M; Kommoss S; du Bois A Expert Rev Anticancer Ther; 2010 Jul; 10(7):1125-36. PubMed ID: 20645701 [TBL] [Abstract][Full Text] [Related]
39. Design and synthesis of 2-(4,5,6,7-tetrahydrothienopyridin-2-yl)-benzoimidazole carboxamides as novel orally efficacious Poly(ADP-ribose)polymerase (PARP) inhibitors. Chen X; Huan X; Liu Q; Wang Y; He Q; Tan C; Chen Y; Ding J; Xu Y; Miao Z; Yang C Eur J Med Chem; 2018 Feb; 145():389-403. PubMed ID: 29335205 [TBL] [Abstract][Full Text] [Related]
40. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair. Dantzer F; Amé JC; Schreiber V; Nakamura J; Ménissier-de Murcia J; de Murcia G Methods Enzymol; 2006; 409():493-510. PubMed ID: 16793420 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]